Related references
Note: Only part of the references are listed.Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse
Abhirup Jayasimhan et al.
CLINICAL SCIENCE (2014)
A Humanized Mouse Model of Autoimmune Insulitis
Ashley A. Viehmann Milam et al.
DIABETES (2014)
Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
Tihamer Orban et al.
DIABETES CARE (2014)
Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
Ronnie Aronson et al.
DIABETES CARE (2014)
Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study
P. Ambery et al.
DIABETIC MEDICINE (2014)
Humanized Mice as a Model for Aberrant Responses in Human T Cell Immunotherapy
Nalini K. Vudattu et al.
JOURNAL OF IMMUNOLOGY (2014)
New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases
Gaurav Mehta et al.
MOLECULAR IMMUNOLOGY (2014)
Insulitis in human type 1 diabetes: a comparison between patients and animal models
Peter In't Veld
SEMINARS IN IMMUNOPATHOLOGY (2014)
Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
Kevan C. Herold et al.
DIABETES (2013)
The clinical and immunological significance of GAD-specific autoantibody and 1-cell responses in type 1 diabetes
Tobias Boettler et al.
JOURNAL OF AUTOIMMUNITY (2013)
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
Antoinette Moran et al.
LANCET (2013)
Recognition of self and altered self by T cells in autoimmunity and allergy
Lei Yin et al.
PROTEIN & CELL (2013)
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
Mark R. Rigby et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial
Stephen E. Gitelman et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
The repertoires of peptides presented by MHC-II in the thymus and in peripheral tissue: a clue for autoimmunity?
Javier A. Collado et al.
FRONTIERS IN IMMUNOLOGY (2013)
The use of animal models in diabetes research
Aileen J. F. King
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs Yet Transiently Impairs β-cell Function
S. Alice Long et al.
DIABETES (2012)
Fall in C-Peptide During First 2 Years From Diagnosis Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes Trial Net Data
Carla J. Greenbaum et al.
DIABETES (2012)
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
Ken T. Coppieters et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
Johnny Ludvigsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Teplizumab Induces Human Gut-Tropic Regulatory Cells in Humanized Mice and Patients
Frank Waldron-Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Combination Therapy With a Dipeptidyl Peptidase-4 Inhibitor and a Proton Pump Inhibitor Induces beta-Cell Neogenesis From Adult Human Pancreatic Duct Cells Implanted in Immunodeficient Mice
Wilma L. Suarez-Pinzon et al.
CELL TRANSPLANTATION (2011)
Rituximab Selectively Suppresses Specific Islet Antibodies
Liping Yu et al.
DIABETES (2011)
Loss of Intra-Islet CD20 Expression May Complicate Efficacy of B-Cell-Directed Type 1 Diabetes Therapies
David V. Serreze et al.
DIABETES (2011)
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
Tihamer Orban et al.
LANCET (2011)
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Tom L. Van Belle et al.
PHYSIOLOGICAL REVIEWS (2011)
Preliminary studies related to anti-interleukin-1β therapy in children with newly diagnosed type 1 diabetes
Kathryn M. Sumpter et al.
PEDIATRIC DIABETES (2011)
Detection of β cell death in diabetes using differentially methylated circulating DNA
Eitan M. Akirav et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human CD3 Transgenic Mice: Preclinical Testing of Antibodies Promoting Immune Tolerance
Chantal Kuhn et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease
John P. Driver et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
Murine Antithymocyte Globulin T-Cell Depletion Is Mediated Predominantly by Macrophages, but the Fas/FasL Pathway Selectively Targets Regulatory T Cells
Kathleen S. Neff et al.
TRANSPLANTATION (2011)
Human Immune System Development and Rejection of Human Islet Allografts in Spontaneously Diabetic NOD-Rag1null IL2rγnull Ins2Akita Mice
Michael A. Brehm et al.
DIABETES (2010)
Residual Insulin Production and Pancreatic β-Cell Turnover After 50 Years of Diabetes: Joslin Medalist Study
Hillary A. Keenan et al.
DIABETES (2010)
Use of Nonobese Diabetic Mice to Understand Human Type 1 Diabetes
Terri C. Thayer et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2010)
An update on the use of NOD mice to study autoimmune (Type 1) diabetes
Rodolfo Jose Chaparro et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Yenkel Grinberg-Bleyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Distinct Phenotype and Function of NK Cells in the Pancreas of Nonobese Diabetic Mice
Hanna Brauner et al.
JOURNAL OF IMMUNOLOGY (2010)
Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes
James F. Mohan et al.
NATURE IMMUNOLOGY (2010)
Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct
Ellen F. Young et al.
AUTOIMMUNITY (2009)
Analysis of islet inflammation in human type 1 diabetes
A. Willcox et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice
W. L. Suarez-Pinzon et al.
DIABETOLOGIA (2009)
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
Mark D. Pescovitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice
Wilma L. Suarez-Pinzon et al.
DIABETES (2008)
β-Cell Mass and Type 1 Diabetes Going, Going, Gone?
Eitan Akirav et al.
DIABETES (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction
Qizhi Tang et al.
IMMUNITY (2008)
B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in FcγR effector functions
Yan Xiu et al.
JOURNAL OF IMMUNOLOGY (2008)
Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice
Maria Koulmanda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation
Greg Simon et al.
DIABETES (2008)
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
Chang-Yun Hu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts
Maria Koulmanda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Effects of autoimmunity and immune therapy on β-cell turnover in type 1 diabetes
Nicole A. Sherry et al.
DIABETES (2006)
Sirolimus is associated with reduced islet engraftment and impaired β-cell function
Nan Zhang et al.
DIABETES (2006)
A comprehensive review of interventions in the NOD mouse and implications for translation
LKM Shoda et al.
IMMUNITY (2005)
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial
JM Kremer et al.
ARTHRITIS AND RHEUMATISM (2005)
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects - A 16-month, randomized, comparative trial
JS Skyler et al.
DIABETES CARE (2005)
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
B Keymeulen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
KC Herold et al.
DIABETES (2005)
Type 1 diabetes genes and pathways shared by humans and NOD mice
LS Wicker et al.
JOURNAL OF AUTOIMMUNITY (2005)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
A spontaneous model for autoimmune myrocarditis using the human MHC molecule HLA-DQ8
JA Taylor et al.
JOURNAL OF IMMUNOLOGY (2004)
Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4
N Ogawa et al.
DIABETES (2004)
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig
JM Kremer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents
C Gysemans et al.
DIABETOLOGIA (2003)
Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice
M Drage et al.
TRANSPLANTATION (2002)
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice
A Rabinovitch et al.
DIABETES (2002)
Oral insulin administration and residual β-cell function in recent-onset type 1 diabetes:: a multicentre randomised controlled trial
L Chaillous et al.
LANCET (2000)
No effect of oral insulin on residual beta-cell function in resent-onset Type I diabetes (the IMDIAB VII)
P Pozzilli et al.
DIABETOLOGIA (2000)
Share Paper
